Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Curcumin Inhibits Expression of Inhibitor of DNA Binding 1 in PC3 Cells and Xenografts

  • Yu, Xiao-Ling (Department of Pathophysiology, Medical College of Qingdao University) ;
  • Jing, Tao (Department of Urinary Surgery, Affiliated Hospital of Qingdao University) ;
  • Zhao, Hui (Department of Pathology, The 401st Hospital of Chinese People's Liberation Army) ;
  • Li, Pei-Jie (Department of Pathophysiology, Medical College of Qingdao University) ;
  • Xu, Wen-Hua (Department of Molecular Biology Laboratory, Medical College of Qingdao University) ;
  • Shang, Fang-Fang (Department of Pathology, The 401st Hospital of Chinese People's Liberation Army)
  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Inhibitor of DNA binding 1 (Id1) plays an important role in genesis and metastatic progression of prostate cancer. We previously reported that down regulation of Id1 by small interfering RNA could inhibit the proliferation of PC3 cells and growth of its xenografted tumors. Curcumin, the active ingredient of turmeric, has shown anti-cancer properties via modulation of a number of different molecular regulators. Here we investigated whether Id1 might be involved in the anti-cancer effects of curcumin in vivo and in vitro. We firstly confirmed that curcumin inhibited cell viability in a dose-dependent fashion, and induced apoptosis in PC3 cells, associated with significant decrease in the mRNA and protein expression of Id1. Similar effects of curcumin were observed in tumors of the PC3 xenografted mouse model with introperitoneal injection of curcumin once a day for one month. Tumor growth in mice was obviously suppressed by curcumin during the period of 24 to 30 days. Both mRNA and protein levels of Id1 were significantly down-regulated in xenografted tumors. Our findings point to a novel molecular pathway for curcumin anti-cancer effects. Curcumin may be used as an Id1 inhibitor to modulate Id1 expression.

Keywords

References

  1. Ao J, Meng J, Zhu L, et al (2012). Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Mol Oncol, 6, 507-15. https://doi.org/10.1016/j.molonc.2012.06.005
  2. Ahlqvist K, Saamarthy K, Syed Khaja AS, Bjartell A, Massoumi R (2013). Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer. Oncogene, 12, 1601-8.
  3. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell, 61, 49-59. https://doi.org/10.1016/0092-8674(90)90214-Y
  4. Cheng YJ, Tsai JW, Hsieh KC, et al (2011). Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway. Cancer Lett, 307, 191-9. https://doi.org/10.1016/j.canlet.2011.04.003
  5. Cheng TS, Chen WC, Lin YY, et al (2013). Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis. Cancer Prev Res, 6, 495-505. https://doi.org/10.1158/1940-6207.CAPR-12-0293-T
  6. Castanon E, Bosch-Barrera J, Lopez I, et al (2013). Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy. J Transl Med, 11, 11-3. https://doi.org/10.1186/1479-5876-11-11
  7. Cimino S, Sortino G, Favilla V, et al (2012). Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev, 2012, 632959.
  8. Dong Z, Wei F, Zhou C, et al (2011). Silencing Id-1 inhibits lymphangiogenesis through down-regulation of VEGF-C in oral squamous cell carcinoma. Oral Oncol, 47, 27-32. https://doi.org/10.1016/j.oraloncology.2010.10.012
  9. Datta R, Halder SK, Zhang B (2013). Role of TGF-${\beta}$ signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells. J Cancer Res Clin Oncol, 4, 563-72.
  10. Forootan S, Wong Y, Dodson A, et al (2007). Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol, 38, 1321-9. https://doi.org/10.1016/j.humpath.2007.02.011
  11. Goel A, Aggarwal BB (2010). Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutrition and Cancer, 62, 919-30. https://doi.org/10.1080/01635581.2010.509835
  12. Gupta SC, Patchva S, Aggarwal BB (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J, 1, 195-218.
  13. Hai-Tao Yin, De-geng Zhang, Xiao-li Wu, Xin-En Huang, Gang Chen (2013). In Vivo Evaluation of Curcumin-loaded Nanoparticles in a A549 Xenograft Mice Model. Asian Pacifc Journal of Cancer Prevention, 14, 409-12 https://doi.org/10.7314/APJCP.2013.14.1.409
  14. Hsiao YC, Yang DL, Hung HL, Lung FD (2013). Structure activity relationships of peptidic analogs of MyoD for the development of Id1 inhibitors as antiproliferative agents. J Pept Sci, 11, 676-83.
  15. Hilchie AL, Furlong SJ, Sutton K, et al (2010). Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria. Nutr Cancer 62:379-89. https://doi.org/10.1080/01635580903441238
  16. Horie S (2012). Chemoprevention of prostate cancer: soy isoflavones and curcumin. Korean J Urol, 53, 665-72. https://doi.org/10.4111/kju.2012.53.10.665
  17. J. Yang, X. Li, R.S. Al-Lamki, et al (2010). Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Circ Res, 107, 252-62. https://doi.org/10.1161/CIRCRESAHA.109.209940
  18. Kang D, Park W, Lee S, Kim JH, Song JJ (2013). Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment. Cell Signal, 25, 1288-300. https://doi.org/10.1016/j.cellsig.2013.01.014
  19. Killian PH, Kronski E, Michalik KM, et al (2012). Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis, 33, 2507-19. https://doi.org/10.1093/carcin/bgs312
  20. Ling M, Lau T, Zhou C, et al (2005). Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis, 26, 1668-76. https://doi.org/10.1093/carcin/bgi128
  21. Ling MT, Kwok WK, Fung MK, Xianghong W, Wong YC (2006). Proteasome mediated degradation of Id-1 is associated with TNFalpha-induced apoptosis in prostate cancer cells. Carcinogenesis, 27, 205-15. https://doi.org/10.1093/carcin/bgi217
  22. Mellick AS, Plummer PN, Nolan DJ, et al (2010). Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth. Cancer Res, 70, 7273-82. https://doi.org/10.1158/0008-5472.CAN-10-1142
  23. Ni X, Zhang A, Zhao Z, Shen Y, Wang S (2012). Demethoxycurcumin inhibits cell proliferation, migration and invasion in prostate cancer cells. Oncol Rep, 8, 85-90.
  24. Patel D, Chaudhary J (2012). Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis. Biochem Biophys Res Commun, 1, 146-51.
  25. Redrado M, Bodegas E, Villaro AC, et al (2013). Spatial-temporal protein expression of Inhibitor of Differentiation-1 (Id1) during fetal embryogenesis and in different mouse and human cancer types. Histol Histopathol, 8, 1029-40.
  26. Rothschild SI, Kappeler A, Ratschiller D, et al (2011). The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer. Lung Cancer, 71, 306-11. https://doi.org/10.1016/j.lungcan.2010.06.018
  27. Strong N, Millena AC, Walker L, Chaudhary J, Khan SA (2013). Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in $TGF{\beta}$ effects on cell proliferation and migration in prostate cancer cells. Prostate, 73, 624-33. https://doi.org/10.1002/pros.22603
  28. Sun W, Guo MM, Han P, et al (2012). Id-1 and the p65 subunit of NF-${\kappa}B$ promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. Carcinogenesis, 33, 810-7. https://doi.org/10.1093/carcin/bgs027
  29. Sharma P, Patel D, Chaudhary J (2012). Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B. Cancer Med, 1, 187-97. https://doi.org/10.1002/cam4.19
  30. Soroceanu L, Murase R, Limbad C, et al (2013). Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target. Cancer Res, 73, 1559-69. https://doi.org/10.1158/0008-5472.CAN-12-1943
  31. Teiten MH, Gaigneaux A, Chateauvieux S, et al (2012). Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines. OMICS, 16, 289-300. https://doi.org/10.1089/omi.2011.0136
  32. Wei X, Zhou D, Wang H, et al (2013). Effects of pyridine analogs of curcumin on growth, apoptosis and NF-${\kappa}B$ activity in prostate cancer PC-3 cells. Anticancer Res, 33, 1343-50.
  33. Wright LE, Frye JB, Lukefahr AL, et al (2013). Curcuminoids block TGF-${\beta}$ signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. J Nat Prod, 3, 316-21.
  34. Xiaoling Yu, Xiaohui Xu, Baojian Han, Rongxiang Zhou (2009). Inhibitor of DNA Binding-1 Overexpression in Prostate Cancer: Relevance to Tumor Differentiation. Pathol Oncol Res, 15, 91-6. https://doi.org/10.1007/s12253-008-9096-y
  35. Y. Kang, C.R. Chen, J. Massague (2003). A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell, 11, 915-26. https://doi.org/10.1016/S1097-2765(03)00109-6
  36. Yin H, Zhang H, Liu B (2013). Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer. Acta Biochim Biophys Sin, 8, 634-40
  37. Yuen HF, Chiu YT, Chan KK, et al (2010). Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1. Br J Cancer, 102, 332-41. https://doi.org/10.1038/sj.bjc.6605480
  38. Yu XL, Jing T, Shang FF, Zhao H, Qi RF (2011). Down regulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro. Eur J Cancer Prev, 20, 9-17. https://doi.org/10.1097/CEJ.0b013e32833ebaa0
  39. Y.Y. Liang, F.C. Brunicardi, X. Lin (2009). Smad3 mediates immediate early induction of Id1 by TGF-beta. Cell Res, 19, 140-8. https://doi.org/10.1038/cr.2008.321
  40. Zhang X, Chen LX, Ouyang L, Cheng Y, Liu B (2012). Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents. Cell Prolif, 45, 466-76. https://doi.org/10.1111/j.1365-2184.2012.00833.x

Cited by

  1. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression vol.126, pp.5, 2015, https://doi.org/10.1182/blood-2015-03-635532
  2. Spices for Prevention and Treatment of Cancers vol.8, pp.8, 2016, https://doi.org/10.3390/nu8080495
  3. The Id-protein family in developmental and cancer-associated pathways vol.15, pp.1, 2017, https://doi.org/10.1186/s12964-016-0161-y
  4. Synthetic curcumin derivative DK1 possessed G2/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells vol.17, pp.1, 2017, https://doi.org/10.1186/s12935-017-0400-3
  5. Dietary Polyphenols in Prevention and Treatment of Prostate Cancer vol.16, pp.2, 2015, https://doi.org/10.3390/ijms16023350